ALERS — Eurobio Scientific SA Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapSuper Stock

Annual cashflow statement for Eurobio Scientific SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	FAS	FAS	FAS	FAS	FAS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	3.15	73.5	60.5	24.9	4.83
Depreciation
Deferred Taxes
Non-Cash Items	0.862	0.92	0.455	-1.25	1.12
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-2.43	-28.3	-3.67	8.84	8.35
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	4.99	54.9	65.9	43.1	26.8
Capital Expenditures	-1.59	-2.3	-1.85	-2.83	-4.05
Purchase of Fixed Assets
Other Investing Cash Flow Items	-2.79	-1.69	-3.62	-139	3.74
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities	-4.39	-3.98	-5.47	-142	-0.318
Financing Cash Flow Items	-1.43	-2.4	-0.882	-1.21	-2.51
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-4.01	7.05	-23.8	82.3	-23.5
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-3.39	57.9	36.8	-16.5	3.09